Literature DB >> 10450010

Clinical application of the Bardex IC Foley catheter.

P Verleyen1, D De Ridder, H Van Poppel, L Baert.   

Abstract

OBJECTIVES: We performed two randomized prospective studies with the silver-coated Bardex IC catheter in order to evaluate the incidence of bacteriuria during short- and medium-term catheterization after urological procedures.
METHODS: During catheterization only consecutive suprapubic urine samples were taken and cultured. After removal of the catheter the patient was allowed one wash-out void, and before the second micturition a suprapubic puncture was performed to collect a culture specimen.
RESULTS: In the first trial, after radical prostatectomy 18 patients with the Bardex IC catheter were compared to 17 patients with a silicon catheter after the same procedure. There was no significant difference in bacteriuria after 14 days (50.0 vs. 53.3%). In the second part of the study 180 patients were evaluated 101 with latex and 79 with Bardex IC catheters. The median catheterization time was 5 days. The results show a significant delay in the onset of bacteriuria when a silver alloy catheter is used (p < 0.003). On day 5 only 6.3% had bacteriuria in the Bardex IC group versus 11.9% in the latex group.
CONCLUSION: We conclude that, after urological procedures, short-term catheterization with the Bardex IC catheter is superior to the classical latex catheter.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10450010     DOI: 10.1159/000068005

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  5 in total

1.  Prevention and treatment of urinary catheter-associated infections.

Authors:  Mayar Al Mohajer; Rabih O Darouiche
Journal:  Curr Infect Dis Rep       Date:  2013-04       Impact factor: 3.725

2.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

3.  epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  R J Pratt; C M Pellowe; J A Wilson; H P Loveday; P J Harper; S R L J Jones; C McDougall; M H Wilcox
Journal:  J Hosp Infect       Date:  2007-02       Impact factor: 3.926

Review 4.  Biomodification Strategies for the Development of Antimicrobial Urinary Catheters: Overview and Advances.

Authors:  Sadiya Anjum; Surabhi Singh; Lepoittevin Benedicte; Philippe Roger; Manoj Panigrahi; Bhuvanesh Gupta
Journal:  Glob Chall       Date:  2017-12-27

Review 5.  Review of Catheter-Associated Urinary Tract Infections and In Vitro Urinary Tract Models.

Authors:  Yvonne J Cortese; Victoria E Wagner; Morgan Tierney; Declan Devine; Andrew Fogarty
Journal:  J Healthc Eng       Date:  2018-10-14       Impact factor: 2.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.